These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34988230)

  • 1. HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis.
    Zeng C; Ye S; Chen Y; Zhang Q; Luo Y; Gai L; Luo B
    J Immunol Res; 2021; 2021():9289719. PubMed ID: 34988230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA
    Tong Y; Wang M; Dai Y; Bao D; Zhang J; Pan H
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):129-141. PubMed ID: 30963785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
    Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
    J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p.
    Zhao Y; Yao R
    Bioengineered; 2021 Dec; 12(1):8724-8737. PubMed ID: 34698001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
    Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
    J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
    Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
    Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
    Hu B; Yang XB; Yang X; Sang XT
    Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma.
    Li R; Chen P; Zhou Y; Lang Y; Zhou C; Ren J; Maimaitiyimin A; Chen Z; Liu C; Mainike A; Ding L
    Sci Rep; 2024 Jul; 14(1):16581. PubMed ID: 39019995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma.
    Fan F; Chen K; Lu X; Li A; Liu C; Wu B
    Hepatol Int; 2021 Apr; 15(2):444-458. PubMed ID: 33219943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA HOXA-AS3 Suppresses the Progression of Atherosclerosis via Sponging miR-455-5p.
    Chi K; Zhang J; Sun H; Liu Y; Li Y; Yuan T; Zhang F
    Drug Des Devel Ther; 2020; 14():3651-3662. PubMed ID: 32982172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression.
    Cao X; Zhang G; Li T; Zhou C; Bai L; Zhao J; Tursun T
    Genes Genomics; 2020 Nov; 42(11):1361-1368. PubMed ID: 32996041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 18. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis.
    Li ZK; Gao LF; Zhu XA; Xiang DK
    Biochem Genet; 2021 Oct; 59(5):1158-1172. PubMed ID: 33687636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C; Li K; Huang R; Zhu J; Yang J
    Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.